companydata.dkcompanydata.dk

VIPERGEN R & D III K/S: Financial statements 2013

CVR: 30355644

Source: annual report 2013, Danish Business Authority

01/01/2013 – 31/12/2013

VIPERGEN R & D III K/S (CVR 30355644) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 804,000 and a net result of DKK -10,661,000 compared with DKK -10,237,000 the year before. The profit margin was -1,326%. Equity in the 2013 report amounted to DKK -1,777,000.

Revenue
DKK 804,000
Profit/Loss
DKK -10,661,000
Equity
DKK -1,777,000
Total Assets
DKK 2,111,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2013804K--10.7M-1.8M-
20120--10.2M8.9M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2013

VIPERGEN R & D III K/S: The 2012 annual report is outJun 5, 2013

VIPERGEN R & D III K/S has published its annual report for 2012. Revenue came to DKK 0, and the net result was DKK -10,237,000.

About VIPERGEN R & D III K/S

VIPERGEN R & D III K/S was a Danish company of the type Kommanditselskab based in København V, founded in 2007. The company has been dissolved on 31 May 2019. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2018, the company reported a gross profit of DKK -10,000 and a net result of DKK -7,000 compared with DKK 211,000 the year before. Equity in the 2018 report amounted to DKK 152,000.

Source: annual report 2018, Danish Business Authority

Other financial years